| Title | Author(s) | Issue date | ???itemlist.??? |
| Phase II study of docetaxel-vinorelbine in platinum-resistant, paclitaxel-pretreated ovarian cancer | Aravantinos, G.; Bafaloukos, D.; Fountzilas, G.; Christodoulou, C.; Papadimitriou, C.; Pavlidis, N.; Kalofonos, H. P.; Gogas, H.; Kosmidis, P.; Dimopoulos, M. A. | 24-Nov-2015 | - |
| Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group | Fountzilas, G.; Skarlos, D.; Dafni, U.; Gogas, H.; Briasoulis, E.; Pectasides, D.; Papadimitriou, C.; Markopoulos, C.; Polychronis, A.; Kalofonos, H. P.; Siafaka, V.; Kosmidis, P.; Timotheadou, E.; Tsavdaridis, D.; Bafaloukos, D.; Papakostas, P.; Razis, E.; Makrantonakis, P.; Aravantinos, G.; Christodoulou, C.; Dimopoulos, A. M. | 24-Nov-2015 | - |
| Postoperative dose-dense sequential versus concomitant administration of epirubicin and paclitaxel in patients with node-positive breast cancer: 5-year results of the Hellenic Cooperative Oncology Group HE 10/00 phase III Trial | Gogas, H.; Dafni, U.; Karina, M.; Papadimitriou, C.; Batistatou, A.; Bobos, M.; Kalofonos, H. P.; Eleftheraki, A. G.; Timotheadou, E.; Bafaloukos, D.; Christodoulou, C.; Markopoulos, C.; Briasoulis, E.; Papakostas, P.; Samantas, E.; Kosmidis, P.; Stathopoulos, G. P.; Karanikiotis, C.; Pectasides, D.; Dimopoulos, M. A.; Fountzilas, G. | 24-Nov-2015 | - |
| Postoperative radiation and concomitant bolus fluorouracil with or without additional chemotherapy with fluorouracil and high-dose leucovorin in patients with high-risk rectal cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group | Fountzilas, G.; Zisiadis, A.; Dafni, U.; Konstantaras, C.; Hatzitheoharis, G.; Liaros, A.; Athanassiou, E.; Dombros, N.; Dervenis, C.; Basdanis, G.; Gamvros, O.; Souparis, A.; Briasoulis, E.; Samantas, E.; Kappas, A.; Kosmidis, P.; Skarlos, D.; Pavlidis, N. | 24-Nov-2015 | - |
| Potential value of PTEN in predicting cetuximab response in colorectal cancer: an exploratory study | Razis, E.; Briasoulis, E.; Vrettou, E.; Skarlos, D. V.; Papamichael, D.; Kostopoulos, I.; Samantas, E.; Xanthakis, I.; Bobos, M.; Galanidi, E.; Bai, M.; Gikonti, I.; Koukouma, A.; Kafiri, G.; Papakostas, P.; Kalogeras, K. T.; Kosmidis, P.; Fountzilas, G. | 24-Nov-2015 | - |
| Predictive and Prognostic Significance of Somatic Mutations in the Tyrosine Kinase (Tk) Domain of Egfr in Nsclc Patients Treated with Single Agent Gefitinib: A Systematic Review and Meta-Analysis | Murray, S.; Evangelou, E.; Linardou, H.; Kosmidis, P.; Bafaloukos, D.; Ioannidis, J. | 24-Nov-2015 | - |
| Predictive Significance of Egfr Somatic Mutations and Gene Copy Number in Nsclc Patients Treated with Single Agent Tyrosine Kinase Inhibitors: A Systematic Review and Meta-Analysis | Murray, S.; Evangelou, E.; Linardou, H.; Dahabreh, I. J.; Kosmidis, P.; Bafaloukos, D.; Ioannidis, J. P. A. | 24-Nov-2015 | - |
| Prognostic factors in Greek patients with small cell lung cancer (SCLC). A Hellenic Cooperative Oncology Group study | Christodolou, C.; Pavlidis, N.; Samantas, E.; Fountzilas, G.; Kouvatseas, G.; Pagdatoglou, K.; Palamidas, F.; Nikolaidis, C.; Angelidou, M.; Kalofonos, H. P.; Kosmidis, P.; Skarlos, D. V. | 24-Nov-2015 | - |
| Prognostic factors influencing complete response to treatment and survival of patients with nasopharyngeal cancer | Kalogera-Fountzila, A.; Kosmidis, P.; Bacoyiannis, C.; Nicolaou, A.; Samantas, E.; Briassoulis, E.; Pavlidis, N.; Skarlos, D.; Daniilidis, J.; Fountzilas, G. | 24-Nov-2015 | - |
| Prognostic variables in greek patients with stage II breast cancer: a Hellenic Cooperative Oncology Group study | Fountzilas, G.; Vasilaros, S.; Koukouras, D.; Malamos, N.; Pectasides, D.; Adamou, A.; Nenopoulou, E.; Kiriakou, K.; Zouvani, I.; Katsohis, K.; Kappas, A.; Skopa, C.; Semoglou, C.; Fahantidis, E.; Konstantaras, C.; Vasilaki, E.; Economopoulos, T.; Bacoyiannis, H.; Bafaloukos, D.; Razi, E.; Polichronis, A.; Androulakis, G.; Papaioannou, T.; Pavlidis, N.; Kosmidis, P.; et al., | 24-Nov-2015 | - |
| A prospective randomized phase III study in non-small-cell lung cancer comparing cisplatin, ifosfamide, vinblastine (VIP) versus cisplatin, ifosfamide and etoposide (VIP-16). Hellenic Co-Operative Oncology Group | Kosmidis, P.; Mylonakis, N.; Fountzilas, G.; Pavlidis, N.; Samantas, E.; Karabelis, A.; Kattis, K.; Skarlos, D. | 24-Nov-2015 | - |
| Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: A randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG) | Skarlos, D. V.; Samantas, E.; Briassoulis, E.; Panoussaki, E.; Pavlidis, N.; Kalofonos, H. P.; Kardamakis, D.; Tsiakopoulos, E.; Kosmidis, P.; Tsavdaridis, D.; Tzitzikas, J.; Tsekeris, P.; Kouvatseas, G.; Zamboglou, N.; Fountzilas, G. | 24-Nov-2015 | - |
| A randomized open-label parallel-group study comparing ondansetron with ondansetron plus dexamethasone in patients with metastatic breast cancer receiving high-dose epirubicin. A Hellenic Cooperative Oncology Group study | Janinis, J.; Giannakakis, T.; Athanasiadis, A.; Fountzilas, G.; Bafaloukos, D.; Kosmidis, P.; Nikolaides, K.; Pavlidis, N.; Skarlos, D. | 24-Nov-2015 | - |
| A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study | Bafaloukos, D.; Linardou, H.; Aravantinos, G.; Papadimitriou, C.; Bamias, A.; Fountzilas, G.; Kalofonos, H. P.; Kosmidis, P.; Timotheadou, E.; Makatsoris, T.; Samantas, E.; Briasoulis, E.; Christodoulou, C.; Papakostas, P.; Pectasides, D.; Dimopoulos, A. M. | 24-Nov-2015 | - |
| A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer: a Hellenic Cooperative Oncology Group study | Fountzilas, G.; Dafni, U.; Dimopoulos, M. A.; Koutras, A.; Skarlos, D.; Papakostas, P.; Gogas, H.; Bafaloukos, D.; Kalogera-Fountzila, A.; Samantas, E.; Briasoulis, E.; Pectasides, D.; Maniadakis, N.; Matsiakou, F.; Aravantinos, G.; Papadimitriou, C.; Karina, M.; Christodoulou, C.; Kosmidis, P.; Kalofonos, H. P. | 24-Nov-2015 | - |
| A randomized study of epirubicin monotherapy every four or every two weeks in advanced breast cancer. A Hellenic Cooperative Oncology Group study | Fountzilas, G.; Athanassiades, A.; Giannakakis, T.; Briasoulis, E.; Bafaloukos, D.; Kalogera-Fountzila, A.; Onienaoum, A.; Kalofonos, H.; Pectasides, D.; Andreopoulou, E.; Bamia, C.; Kosmidis, P.; Pavlidis, N.; Skarlos, D. | 24-Nov-2015 | - |
| Recombinant interferon ALFA-2A in combination with carboplatin, vinblastine, and bleomycin in the treatment of advanced malignant melanoma | Bafaloukos, D.; Pavlidis, N.; Fountzilas, G.; Skarlos, D.; Klouvas, G.; Makrantonakis, P.; Giannakakis, T.; Tsavaris, N.; Kosmidis, P. | 24-Nov-2015 | - |
| Subcutaneous low doses of interleukin-2 and recombinant interferon alpha with carboplatin and vinblastine in patients with advanced melanoma | Bafaloukos, D.; Fountzilas, G.; Skarlos, D.; Pavlidis, N.; Bakoyiannis, C.; Karvounis, N.; Kosmidis, P. | 24-Nov-2015 | - |
| Subsets of tumors responsive to cisplatin or carboplatin combinations in patients with carcinoma of unknown primary site. A Hellenic Cooperative Oncology Group Study | Pavlidis, N.; Kosmidis, P.; Skarlos, D.; Briassoulis, E.; Beer, M.; Theoharis, D.; Bafaloukos, D.; Maraveyas, A.; Fountzilas, G. | 24-Nov-2015 | - |
| Treatment of non-small cell lung cancer with gefitinib ('Iressa', ZD1839): the Greek experience with a compassionate-use program | Razis, E.; Skarlos, D.; Briasoulis, E.; Dimopoulos, M.; Fountzilas, G.; Lambropoulos, S.; Rigatos, S.; Kopterides, P.; Efstathiou, H.; Tzamakou, E.; Bakoyannis, C.; Pectasides, D.; Makatsoris, T.; Varthalitis, G.; Papadopoulos, S.; Kosmidis, P. | 24-Nov-2015 | - |
